Frontier Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-5,440
| Closed | -$250K | – | 388 |
|
|
2020
Q4 | $250K | Sell |
5,440
-578
| -10% | -$26.6K | 0.02% | 320 |
|
|
2020
Q3 | $283K | Sell |
6,018
-240
| -4% | -$11.3K | 0.03% | 289 |
|
|
2020
Q2 | $319K | Sell |
6,258
-13,600
| -68% | -$693K | 0.03% | 269 |
|
|
2020
Q1 | $941K | Buy |
19,858
+10,840
| +120% | +$514K | 0.15% | 122 |
|
|
2019
Q4 | $530K | Sell |
9,018
-12,280
| -58% | -$722K | 0.09% | 172 |
|
|
2019
Q3 | $1.14M | Sell |
21,298
-1,417
| -6% | -$75.6K | 0.17% | 119 |
|
|
2019
Q2 | $1.14M | Sell |
22,715
-2,957
| -12% | -$148K | 0.17% | 111 |
|
|
2019
Q1 | $1.34M | Buy |
25,672
+2,039
| +9% | +$107K | 0.18% | 123 |
|
|
2018
Q4 | $1.13M | Buy |
23,633
+887
| +4% | +$42.4K | 0.17% | 130 |
|
|
2018
Q3 | $1.14M | Buy |
22,746
+212
| +0.9% | +$10.6K | 0.11% | 140 |
|
|
2018
Q2 | $1.14M | Buy |
+22,534
| New | +$1.14M | 0.16% | 134 |
|
|
2017
Q1 | – | Sell |
-4,448
| Closed | -$214K | – | 409 |
|
|
2016
Q4 | $214K | Sell |
4,448
-398
| -8% | -$19.1K | 0.04% | 346 |
|
|
2016
Q3 | $261K | Buy |
+4,846
| New | +$261K | 0.04% | 299 |
|
|
2016
Q1 | – | Sell |
-4,349
| Closed | -$219K | – | 359 |
|
|
2015
Q4 | $219K | Buy |
4,349
+120
| +3% | +$6.04K | 0.04% | 298 |
|
|
2015
Q3 | $203K | Buy |
+4,229
| New | +$203K | 0.03% | 307 |
|